Insider · CIK 0001859694
Eli N. Glezer
Files at OMIC (Singular Genomics Systems, Inc.). First filing -, latest -.
In brief
Eli N. Glezer files SEC Form 4 as officer at OMIC (Singular Genomics Systems, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Eli N. Glezer has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | DDisposition to issuer Common Stock | -155,583 | - | - | 0 | Feb 25, 2025 |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -16,666 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -7,999 | $0.00 | $0 | 0 | Feb 25, 2025 |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -6,000 | $20.00 | $120k | 0 | Feb 25, 2025 |
| Feb 21, 2025 | OMIC Singular Genomics Systems, Inc. | DDisposition to issuer Restricted Stock Unitderivative | -2,250 | $20.00 | $45k | 0 | Feb 25, 2025 |
| Feb 9, 2025 | OMIC Singular Genomics Systems, Inc. | MOption exercise Common Stock | +500 | - | - | 155,583 | Feb 11, 2025 |
| Feb 9, 2025 | OMIC Singular Genomics Systems, Inc. | MOption exercise Restricted Stock Unitsderivative | -500 | - | - | 6,000 | Feb 11, 2025 |
| Dec 15, 2024 | OMIC Singular Genomics Systems, Inc. | MOption exercise Common Stock | +250 | - | - | 155,083 | Dec 17, 2024 |
| Dec 15, 2024 | OMIC Singular Genomics Systems, Inc. | MOption exercise Restricted Stock Unitsderivative | -250 | - | - | 2,250 | Dec 17, 2024 |
| Nov 9, 2024 | OMIC Singular Genomics Systems, Inc. | MOption exercise Common Stock | +500 | - | - | 154,833 | Nov 13, 2024 |
| Nov 9, 2024 | OMIC Singular Genomics Systems, Inc. | MOption exercise Restricted Stock Unitsderivative | -500 | - | - | 6,500 | Nov 13, 2024 |
Questions about Eli N. Glezer
Answered from the filings on this page, as of the latest one.
Is Eli N. Glezer buying or selling?
Eli N. Glezer has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Eli N. Glezer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eli N. Glezer has 0.
Where does Eli N. Glezer file Form 4?
Eli N. Glezer has filed Form 4 at OMIC (Singular Genomics Systems, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.